Skip to main content
Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.
Gastritis cystica polyposa.
Hepatocarcinoma in viral and metabolic liver disease.
Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics.
Extraintestinal manifestations of inflammatory bowel disease.
Body mass index and elbow range of motion in a healthy pediatric population: a possible mechanism of overweight in children.
Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy.
Regulatory regions in the rat lactase-phlorizin hydrolase gene that control cell-specific expression.
Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.